Multiplex Assays Market
Opportunities and Forecasts, 2014- 2022
Multiplex Assays Market: Future and Growth • The global market was valued at $3,470 million in 2015 and is expected to garner $5,720 million by 2022 • Registering a CAGR of 7.4% during the forecast period 2016-2022 • The protein-based multiplex assays segment held over two-thirds share of the total market in 2015
• The multiplex assays reagents & consumable market held the highest share of three-fourths in 2015 • Pharmaceuticals & biotechnological companies in end users held the highest market share of multiplex assays market in 2015
Multiplex Assays Market: Factors for Market Growth • Multiplex assays analyze multiple analytes at the same time • Extract more data from a sample in less time as compared to single-plex assays
• Increase in research & development activities for the detection of biomarkers for various diseases & treatment options of the diseases • Rise in adoption of personalized medicine for increasing safety & efficacy of therapies • Benefits, such as lower operational cost & reduced labor • Technological advancements
Multiplex Assays Market: Key Players • The multiplex assays reagents & consumable market accounted for the highest market share for product segment in 2015, and is also estimated to grow at the highest CAGR of 7.7% in the analysis period. • By application, research and development held the highest market share and expected to lead the market during the analysis period. • U.S. was the highest shareholder in the North American multiplex assays market, accounting for six-sevenths share in 2015. • China is expected to show the highest growth rate during the analysis period in the Asia-Pacific multiplex assays market.
Multiplex Assays Market Segmentation The market is segmented into various types:
By Type
By Product
• Nucleic AcidBased Multiplex Assays • Protein-Based Multiplex Assays
• Multiplex Assay Reagents & Consumable • Multiplex Assay Instruments & Accessories • Multiplex Assay Software and Services
By Technology • Multiplex PCR • Multiplex Protein Microarray
By Application • Companion Diagnostics • Research & Development • Clinical Diagnostics
By End User • Hospitals • Clinical Laboratories • Research Institutes • Pharmaceuticals & Biotechnological Companies
Multiplex Assays Market Segmentation • Geographically, the global multiplex assays market is analyzed by four regions, namely, North America, Europe, Asia-Pacific, and LAMEA • North America was the highest revenue contributor with approximately half of the share in 2015, and is attributed to the ample amount of expenditure in healthcare, research & development, well-established healthcare system, and higher demand for technically advanced devices for research work
• Asia-Pacific is anticipated to grow with the highest CAGR during the analysis period, owing to rise in healthcare expenditure, increase in per capita income & improved healthcare infrastructure.
Multiplex Assays Market: Key Players
• • • • • • • • • •
Luminex Corporation Thermo Fisher Scientific, Inc. Illumina, Inc. Bio-Rad Laboratories, Inc. QIAGEN N.V. Becton, Dickinson and Company Abcam PLC. Seegene Inc. Meso Scale Diagnostics, LLC. and Randox Laboratories Ltd.
Summary: Protein-based multiplex assays are expected to dominate global multiplex assays market during the forecast period, owing to their rise in adoption to analyze unknown proteins and their functions simultaneously and precisely
To know more about the Multiplex Assays Market, visit: https://www.alliedmarketresearch.com/multiplex-assays-market
Follow us on: